Cargando…
Targeting Nrf2 for the treatment of Duchenne Muscular Dystrophy
Imbalances in redox homeostasis can result in oxidative stress, which is implicated in various pathological conditions including the fatal neuromuscular disease Duchenne Muscular Dystrophy (DMD). DMD is a complicated disease, with many druggable targets at the cellular and molecular level including...
Autores principales: | Kourakis, Stephanie, Timpani, Cara A., de Haan, Judy B., Gueven, Nuri, Fischer, Dirk, Rybalka, Emma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695875/ https://www.ncbi.nlm.nih.gov/pubmed/33246292 http://dx.doi.org/10.1016/j.redox.2020.101803 |
Ejemplares similares
-
Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?
por: Kourakis, Stephanie, et al.
Publicado: (2021) -
Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?
por: Kourakis, Stephanie, et al.
Publicado: (2020) -
Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy
por: Timpani, Cara A., et al.
Publicado: (2020) -
Nitric Oxide (NO) and Duchenne Muscular Dystrophy: NO Way to Go?
por: Timpani, Cara A., et al.
Publicado: (2020) -
Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy
por: Timpani, Cara A., et al.
Publicado: (2017)